<?xml version="1.0" ?>
<document id="4eb0645a5ab563b06ec101914438267b6552a95e">
  <chunk id="4eb0645a5ab563b06ec101914438267b6552a95e.c0" text="Synthesis and Anticancer Activities of Glycyrrhetinic Acid Derivatives">
    <entity charOffset="0-9" id="4eb0645a5ab563b06ec101914438267b6552a95e.c0.e0" ontology_id="GO_0009058" text="Synthesis" type="gene_function"/>
  </chunk>
  <chunk id="4eb0645a5ab563b06ec101914438267b6552a95e.c1" text="A total of forty novel glycyrrhetinic acid (GA) derivatives were designed and synthesized. The cytotoxic activity of the novel compounds was tested against two human breast cancer cell lines (MCF-7, MDA-MB-231) in vitro by the MTT method. The evaluation results revealed that, in comparison with GA, compound 42 shows the most promising anticancer activity (IC 50 1.88˘0.20 and 1.37˘0.18 µM for MCF-7 and MDA-MB-231, respectively) and merits further exploration as a new anticancer agent.">
    <entity charOffset="166-179" id="4eb0645a5ab563b06ec101914438267b6552a95e.c1.e0" ontology_id="HP_0003002" text="breast cancer" type="phenotype"/>
    <entity charOffset="173-179" id="4eb0645a5ab563b06ec101914438267b6552a95e.c1.e1" ontology_id="HP_0002664" text="cancer" type="phenotype"/>
  </chunk>
</document>
